Clinical Trial Update: Pharmacokinetic and Pharmacodynamic Profiles of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients With Asthma [Phase 1]

View source ↗

Summary

A Phase 1 study reports the pharmacokinetic and pharmacodynamic profiles of albuterol delivered by Spiromax and ProAir HFA inhalers in pediatric patients with a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Albuterol Spiromax (albuterol)
• ProAir HFA (albuterol)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Asthma | Phase 1 | Status: COMPLETED